contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


raysearch-laboratories-another-three-centers-under-the-french-unicancer-framework-select-raystation

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

RaySearch Laboratories is a biotechnology company. The company specializes in the development of software solutions for the healthcare industry. An area where the company's products are used is in the treatment of cancer and other serious diseases. The company's products include products for dose planning and information systems. Various features include machine learning, computational speed, automated planning, virtual simulation, adaptive therapy, and digital workflows. The products are used by several clinics around the global market.

Raysearch Laboratories

RaySearch Laboratories AB (publ) is pleased to announce that Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges, have placed orders for...

<div class="abstract">RaySearch Laboratories AB (publ) is pleased to announce that Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges, have placed orders for the treatment planning system RayStation®* under the Unicancer 2019 Framework agreement.</div>Unicancer is a French hospital network exclusively specialized in oncology. It brings together 18 comprehensive cancer centers and two affiliated centers, spread across 22 hospitals in France. Annually, more than 600,000 patients are treated at a Unicancer center and across the network, 787 clinical trials are ongoing.The orders from Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges were received during the summer of 2024. The total order value from the three sites was 3.2 MEUR excluding service contracts, of which about one third was recognized as revenue in Q2 and two thirds in Q3.In total, 14 centers, out of the 20 centers that constitute the Unicancer network, as well as two public hospitals, have purchased RayStation under the Unicancer 2019/PPE019 Framework agreements (four years). RayStation and RayCare have now been selected in a new Unicancer Framework agreement (2023), which applies from August 2024.Johan Löf, founder and CEO, RaySearch: "I am very happy about the agreements with these important French centers, especially since they are all comprehensive cancer centers. RayStation is an excellent starting point, but our vision is that our software should support all the disciplines included in a comprehensive cancer center."

RaySearch Laboratories: Another three centers under the French Unicancer framework select RayStation

Tilmeld dig vores nyhedsbrev - ingen konto nødvendig!